Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty
- 31 May 1991
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (6) , 111-117
- https://doi.org/10.1016/0735-1097(91)90946-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Heparin‐like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cellsJournal of Cellular Physiology, 1988
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988
- Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1987
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- The effect of glucocorticoids on lyso-PAF formationin vitro andin vivoInflammation Research, 1986
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- Glucocorticoid influence on growth of vascular wall cells in cultureJournal of Cellular Physiology, 1982
- Dynamic coronary tone in precipitation, exacerbation and relief of angina pectorisThe American Journal of Cardiology, 1981